These patients displayed the following inclusion criteria: low risk MDS, anemia refractory to erythropoiesis stimulating agents or high endogenous level of EPO (>500IU/L) and plasma ferritin (< 1000μg/l). Here, EPO is linked to anemia (phenotype).